NIH-funded research U01 cooperative agreement

Personalized Immunomodulatory Therapy for HIV-related Cryptococcal Meningitis

Official title: Strategy Trial of Personalized Immunomodulatory Therapy for HIV-related Cryptococcal Meningitis

Funded at University of Minnesota · NIH-11615077 · Data updated 2026-11-12

A patient-focused study investigates a personalized treatment approach to improve outcomes for people with HIV who develop cryptococcal meningitis.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startSeptember 21, 2026
Project endAugust 31, 2031
Funding year2026
Award (this year)$314,988
NIH project number3U01AI198071-01S1
Project IDNIH-11615077 on NIH RePORTER

Who could benefit from this research

Could help

Adults with HIV and cryptococcal meningitis who are receiving standard antifungal treatment.

Less likely to help

People without HIV-related cryptococcal meningitis or those not eligible for immunomodulatory approaches may not benefit.

What this research studies

This grant supports a strategy trial that aims to tailor immune-based therapy for adults living with HIV and cryptococcal meningitis. It builds on emerging ideas that the patient’s immune response, not just antifungal drugs, influences recovery. The study will investigate how to optimize immunomodulatory strategies alongside standard antifungal therapy to reduce death and complications. Participants may be adults with HIV who are receiving care in settings where cryptococcal meningitis is a major health concern.

Why it matters

Potential benefit: If successful, the approach could reduce mortality and improve recovery for HIV-related cryptococcal meningitis by personalizing immune support.

How similar studies have gone: Previous research suggests the host immune response contributes to outcomes, but personalized immunomodulation in this context is an emerging area with ongoing exploration.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Boulware, David R — University of Minnesota
  • Study coordinator: Boulware, David R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.